Bcl-2 expression and apoptosis induction in human HL60 leukaemic cells treated with a novel organotellurium(IV) compound RT-04

Organotellurium(IV) compounds have been reported to have multiple biological activities including cysteine protease-inhibitory activity, mainly cathepsin B. As cathepsin B is a highly predictive indicator for prognosis and diagnosis of cancer, a possible antitumor potential for these new compounds is expected. In this work, it was investigated the effectiveness of organotellurium(IV) RT-04 to produce lethal effects in the human promyelocytic leukaemia cell line HL60. Using the MTT tetrazolium reduction test, and trypan blue exclusion assay, the IC50 for the compound after 24 h incubation was 6.8 and 0.35 μM, respectively. Moreover, the compound was found to trigger apoptosis in HL60 cells, inducing DNA fragmentation and caspase-3, -6, and -9 activations. The apoptsosis-induced by RT-04 is probably related to the diminished Bcl-2 expression, observed by RT-PCR, in HL60-treated cells. In vivo studies demonstrated that the RT-04 treatment (2.76 mg/kg given for three consecutive days) produces no significant toxic effects for bone marrow and spleen CFU-GM. However, higher doses (5.0 and 10 mg/kg) produced a dose-dependent reduction in the number of CFU-GM of RT-04-treated mice. These results suggest that RT-04 is able to induce apoptosis in HL60 cells by Bcl-2 expression down-modulation. Further studies are necessary to better clarify the effects of this compound on bone marrow normal cells46725402545CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQFUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESPNão temNão te

Bcl-2 Expression And Apoptosis Induction In Human Hl60 Leukaemic Cells Treated With A Novel Organotellurium(iv) Compound Rt-04

Organotellurium(IV) compounds have been reported to have multiple biological activities including cysteine protease-inhibitory activity, mainly cathepsin B. As cathepsin B is a highly predictive indicator for prognosis and diagnosis of cancer, a possible antitumor potential for these new compounds is expected. In this work, it was investigated the effectiveness of organotellurium(IV) RT-04 to produce lethal effects in the human promyelocytic leukaemia cell line HL60. Using the MTT tetrazolium reduction test, and trypan blue exclusion assay, the IC50 for the compound after 24 h incubation was 6.8 and 0.35 μM, respectively. Moreover, the compound was found to trigger apoptosis in HL60 cells, inducing DNA fragmentation and caspase-3, -6, and -9 activations. The apoptsosis-induced by RT-04 is probably related to the diminished Bcl-2 expression, observed by RT-PCR, in HL60-treated cells. In vivo studies demonstrated that the RT-04 treatment (2.76 mg/kg given for three consecutive days) produces no significant toxic effects for bone marrow and spleen CFU-GM. However, higher doses (5.0 and 10 mg/kg) produced a dose-dependent reduction in the number of CFU-GM of RT-04-treated mice. These results suggest that RT-04 is able to induce apoptosis in HL60 cells by Bcl-2 expression down-modulation. Further studies are necessary to better clarify the effects of this compound on bone marrow normal cells. © 2008 Elsevier Ltd. All rights reserved.46725402545Alonso, S., Minty, A., Bourlet, Y., Buckingham, M., Comparison of three actin-coding sequences in the mouseevolutionary relationships between the actin genes of warm-blooded vertebrates (1986) J. Mol. Evol., 23, pp. 11-22Baum, C., Fairbairn, L.J., Hildinger, M., Lashford, L.S., Hegewisch-Becker, S., Rafferty, J.A., New perspectives for cancer chemotherapy by genetic protection of haematopoietic cells (1999) Expert Rev. Mol. Med., 12, pp. 1-28Brito, J.M., Borojevic, R., Liver granulomas in schistosomiasis: mast cell-dependent induction of SCF expression in hepatic satellite cells is mediated by TNF-alpha (1997) J. Leuk. Biol., 62, pp. 389-396Cao, G., Xiao, M., Sun, F., Xiao, X., Pei, W., Li, J., Graham, S.H., Chen, J., Cloning of a novel Apaf-1-interacting protein: a potent suppressor of apoptosis and ischemic neuronal cell death (2004) J. Neurosci., 24, pp. 6189-6201Chen, F., Vallyathan, V., Castranova, V., Shi, X., Cell apoptosis induced by carcinogenic metals (2001) Mol. Cell Biochem., 222, pp. 183-188Chen, M., Wang, J., Initiator caspases in apoptosis signaling pathways (2002) Apoptosis, 4, pp. 313-319Cohen, G.M., Caspases: the executioners of apoptosis (1997) Biochem. J., 326, pp. 1-16Cunha, R.L.O.R., Urano, M.E., Chagas, J.R., Almeida, P.C., Bincoletto, C., Tersariol, I.L.S., Comasseto, J.V., Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B (2005) Bioorg. Med. Chem. Lett., 15, pp. 755-760Engman, L., Al-Maharik, N., McNaughton, M., Birmingham, A., Powis, G., Thioredoxin reductase and cancer cell growth inhibition by organotellurium compounds that could be selectively incorporated into tumor cells (2003) Bioorg. Med. Chem., 11, pp. 5091-5100Fesik, S.W., Promoting apoptosis as a strategy for cancer drugs discovery (2005) Nat. Rev., 5, pp. 876-885Frei, G.M., Lebenthal, I., Albeck, M., Albeck, A., Sredni, B., Neutral and positively charged thiols synergize the effect of the immunomodulator AS101 as a growth inhibitor of Jurkat cells, by increasing its uptake (2007) Biochem. Pharmacol., 74, pp. 712-722Hanahan, D., Weinberg, R.A., The hallmarks of cancer (2000) Cell, 100, pp. 57-70Harrison, P.R., Lanfear, J., Wu, L., Fleming, J., McGarry, L., Blower, L., Chemopreventive and growth inhibitory effects of selenium (1997) Biomed. Environ. Sci., 10, pp. 235-245Jiang, X., Wang, X., Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1 (2000) J. Biol. Chem., 275, pp. 31199-31203Liu, X., Zou, H., Slaughter, C., Wang, X., DFF a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis (1997) Cell, 89, pp. 175-184Lovschall, H., Eiskjaer, M., Arenholt-Bindslev, D., Formaldehyde cytotoxicity in three human cell types assessed in three different assays (2002) Toxicol. In Vitro, 16, pp. 63-69Malerba, I., Casati, S., Diodovich, C., Parent-Massin, D., Gribaldo, L., Inhibition of CFU-E/BFU-E and CFU-GM colony growth by cyclophosphamide, 5-fluorouracil and taxol: development of a high-throughput in vitro method (2004) Toxicol. In Vitro, 3, pp. 293-300McNaughton, M., Engman, L., Birmingham, A., Powis, G., Cotgreave, I.A., Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth (2004) J. Med. Chem., 47, pp. 233-239Metcalf, D., (1984) Clonal Culture of Hemopoietic Cells: Techniques and Applications, , Elsevier, Amsterdam p. 167Minko, T., Kopecková, P., Kopecek, J., Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells (2001) J. Contr. Release, 71, pp. 227-237Mosmmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay (1983) J. Immunol. Meth., 65, pp. 55-63Newell, D.R., Silvester, J., McDowell, C., Burtles, S.S., The Cancer Research UK experience of pre-clinical toxicology studies to support early clinical trials with novel cancer therapies (2004) Eur. J. Cancer, 40, pp. 899-906. , Cancer Research UKNoda, Y., Suzuki, T., Kahara, A., Yotsuyanagi, A., Hasegawa, T., Hayshi, M., Sofuni, T., Okada, S., In vivo genotoxicity evaluation of dimethylarsinic in Muat™ mouse (2002) Mut. Ras. Gen Toxicol. Muagen., 513, pp. 205-212Nogueira, C.W., Zeni, G., Rocha, J.B., Organoselenium and organotellurium compounds: toxicology and pharmacology (2004) Chem. Rev., 104, pp. 6255-6285Oltersdorf, T., Elmore, S.W., Shoemaker, A.R., An inhibitor of Bcl-2 family proteins induces regression of solid tumours (2005) Nature, 435, pp. 677-681Osorio, L.M., De Santiago, A., Aguilar-Santelises, M., Mellstedt, H., Jondal, M., CD6 ligation modulates Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM (1997) Blood, 89, pp. 2833-2841Pailard, F., Finot, F., Mouche, I., Perez, A., Vericat, J.A., Use of primary cultures of rat hepatocytes to predict toxicity in the early development of new chemical entities (1999) Toxicol. In vitro, 13, pp. 693-700Parent-Massin, D., Relevance of clonogenic assays in hematotoxicology (2001) Cell Biol. Toxicol., 17, pp. 87-94Pessina, A., Albella, B., Bayo, M., Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics (2003) Toxicol. Sci., 75, pp. 355-367Rinehart, J., Adjei, A.A., Lorusso, P.M., Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer (2004) J. Clin. Oncol., 22, pp. 4456-4462Rodriguez, J., Lazebnik, Y., Caspase-9 and APAF-1 form an active holoenzyme (1999) Genes Dev., 13, pp. 3179-3184Sailer, B.L., Liles, N., Dickerson, S., Sumners, S., Chasteen, T.G., Oraganotellurium compound toxicity in a promyelocytic cell line compared to non-tellurium-containing organic analog (2004) Toxicol. In vitro, 18, pp. 475-482Stewart, M.S., Davis, R.L., Walsh, L.P., Pence, B.C., Induction of differentiation and apoptosis by sodium selenite in human colonic carcinoma cells (HT29) (1997) Cancer Lett., 117, pp. 35-40Wei, M.C., Zong, W.X., Cheng, E.H., Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death (2001) Science, 292, pp. 727-730Wieslander, E., Engman, L., Svensjö, E., Antioxidative properties of organotellurium compounds in cell systems (1998) Biochem. Pharmacol., 55, pp. 573-584Zeni, G., Chieffi, A., Cunha, R.L.O.R., Stefani, H.A., Zukerman-Schpector, J., Comasseto, J.V., (1999) Organometallics, 18, pp. 803-806Zimmermann, K.C., Bonzon, C., Green, D.R., The machinery of programmed cell death (2001) Pharmacol. Ther., 92, pp. 57-7

Pre-clinical Antitumour Evaluation Of Biphosphinic Palladacycle Complex In Human Leukaemia Cells

Previous studies reported by our group have introduced a new antitumoural drug called Biphosphinic Palladacycle Complex (BPC). In this paper we show that BPC causes apoptosis in leukaemia cells (HL60 and Jurkat), but not in normal human lymphocytes. IC50 values obtained for both cell lines using the MTT and trypan blue exclusion assays 5 h after BPC treatment were lower than 8.0 μM. Using metachromatic fluorophore, acridine orange, we observed that BPC elicited lysosomal rupture of leukaemic cells. Furthermore, BPC triggered caspase-3 and caspase-6 activation and apoptosis in cell lines, inducing chromatin condensation, apoptotic bodies, and DNA fragmentation. Interestingly, the lysosomal cathepsin B inhibitor CA074 markedly decreased BPC-induced caspase-3 and caspase-6 activation as well as cell death. Lysosomal BPC-induced membrane destabilisation was not dependent on reactive oxygen species generation, which was consistent with the absence of cellular HL60 and Jurkat membrane lipid peroxidation. We conclude that, following BPC treatment, lysosomal membrane rupture precedes cell death and the apoptotic signalling pathway is initiated by the release of cathepsin B in the cytoplasm of leukaemia cells. As no toxic effects for human lymphocytes were observed, we suggest that BPC is more selective for transformed cells, mainly due to their exacerbated lysosome expression. © 2008 Elsevier Ireland Ltd. All rights reserved.1773181189Hanahan, D., Weinberg, R.A., The hallmarks of cancer (2000) Cell, 100, pp. 57-70Leist, M., Jäättelä, M., Triggering of apoptosis by cathepsins (2001) Cell Death Differ., 8, pp. 324-326Jäättelä, M., Multiple cell death pathways as regulators of tumour initiation and progression (2004) Oncogene, 23, pp. 2746-2756Kroemer, G., Jäättelä, M., Lysosomes and autophagy in cell death control (2005) Nat. Rev. Cancer, 5, pp. 886-897Foghsgaard, L., Wissing, D., Mauch, D., Lademann, U., Bastholm, L., Boes, M., Elling, F., Jäättelä, M., Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor (2001) J. Cell Biol., 153, pp. 999-1010Leist, M., Jäättelä, M., Four deaths and a funeral: from caspases to alternative mechanisms (2001) Nat. Rev. Mol. Cell Biol., 2, pp. 589-598Jäättelä, M., Programmed cell death: many ways for cells to die decently (2002) Ann. Med., 34, pp. 480-488Roberts, L.R., Adjei, P.N., Gores, G.J., Cathepsins as effector proteases in hepatocyte apoptosis (1999) Cell Biochem. Biophys., 30, pp. 71-88Nishimura, Y., Sameni, M., Sloane, B.F., Malignant transformation alters intracellular trafficking of lysosomal cathepsin D in human breast epithelial cells (1998) Pathol. Oncol. Res., 4, pp. 283-296Démoz, M., Castino, R., Dragonetti, A., Raiteri, E., Baccino, F.M., Isidoro, C., Transformation by oncogenic ras-p21 alters the processing and subcellular localization of the lysosomal protease cathepsin D (1999) J. Cell. Biochem., 73, pp. 370-378Guicciardi, M.E., Leist, M., Gores, G.J., Lysosomes in cell death (2004) Oncogene, 23, pp. 2881-2890Bincoletto, C., Tersariol, I.L.S., Oliveira, C.R., Dreher, S., Fausto, D.M., Soufen, M.A., Nascimento, F.D., Caires, A.C.F., Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents (2005) Biol. Med. Chem., 13, pp. 3047-3055Barbosa, C.M.V., Oliveira, C.R., Nascimento, F.D., Smith, M.C.M., Fausto, D.M., Soufen, M.A., Sena, E., Caires, A.C.F., Biphosphinic palladacycle complex mediates lysosomal-membrane permeabilization and cell death in K562 leukaemia cells (2006) Eur. J. Pharmacol., 7, pp. 37-47A.C.F. Caires, C. Bincoletto, I.L.S. Tersariol, Compostos ciclopaladados. Composição e unidade de dosagem. Métodos de inibição da atividade de proteínas e enzimas. Metodologias de tratamento de distúrbios e doenças relacionadas com tais enzimas. Método de modulação do sistema imunológico, PI 0204160-0, RPI (2002) 1666Melo, P.S., Durán, N., Haun, M., Citotoxicity of derivatives from dehydrocrotonin on V79 cells and Escherichia coli (2001) Toxicology, 159, pp. 135-141Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays (1983) J. Immunol. Methods, 65, pp. 55-63Olsson, G.M., Brunmark, A., Brunk, U.T., Acridine orange-mediated photodamage of microsomal- and lysosomal fractions (1989) Virchows Arch. B. Cell Pathol. Incl. Mol. Pathol., 56, pp. 247-257Rundquist, I., Olsson, M., Brunk, U., Cytofluorometric quantitation of acridine orange uptake by cultured cells (1984) Acta Pathol. Microbiol. Immunol. Scand. A, 92, pp. 303-309Zdolsek, J.M., Olsson, G.M., Brunk, U.T., Photooxidative damage to lysosomes of cultured macrophages by acridine orange (1990) Photochem. Photobiol., 51, pp. 67-76Brunk, U.T., Svensson, I., Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak (1999) Redox Rep., 4, pp. 3-11Antunes, F., Cadenas, E., Brunk, U.T., Apoptosis induced by exposure to a low steady state concentration of H2O2 is a consequence of lysosomal rupture (2001) Biochem. J., 356 (PART 2), pp. 549-555Neuzil, J., Zhao, M., Ostermann, G., Sticha, M., Gellert, N., Weber, C., Eaton, J.W., Brunk, U.T., Alpha-tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosomal instability (2002) Biochem. J., 362 (PART 3), pp. 709-715Almeida, P.C., Nantes, I.L., Rizzi, C.C., Júdice, W.A., Chagas, J.R., Juliano, L., Nader, H.B., Tersariol, I.L., Cysteine proteinase activity regulation. A possible role of heparin and heparin-like glycosaminoglycans (1999) J. Biol. Chem., 274, pp. 30433-30438Mishell, B.B., Shiqi, S.M., Henry, C., Chen, E.L., North, J., Gallily, R., Slomich, M., Good, A.H., Preparation of mouse cell suspensions (1980) Selected Methods in Cellular Immunology, pp. 21-22. , Mishell B.B., and Shiqi S.M. (Eds), Freeman, New YorkMpoke, S.S., Wolfe, J., Differential staining of apoptotic nuclei in living cells: application to macronuclear elimination in Tetrahymena (1997) J. Histochem. Cytochem., 45, pp. 675-683Büyükavci, M., Ozdemir, O., Buck, S., Stout, M., Ravindranath, Y., Savasan, S., Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect (2006) Fundam. Clin. Pharmacol., 20, pp. 73-79Fesik, S.W., Promoting apoptosis as a strategy for cancer drugs discovery (2005) Nat. Rev. Cancer, 5, pp. 876-885Nicholson, D.W., Caspase structure, proteolytic substrates, and function during apoptotic cell death (1999) Cell Death Differ., 6, pp. 1028-1042Erdal, H., Berndtsson, M., Castro, J., Brunk, U., Shoshan, M.C., Linder, S., Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis (2005) Proc. Natl. Acad. Sci. U.S.A., 102, pp. 192-197Banker, D.E., Groudine, M., Willman, C.L., Norwood, T., Appelbaum, F.R., Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents (1998) Leuk. Res., 22, pp. 221-239Fehrenbacher, N., Jäättelä, M., Lysosomes as targets for cancer therapy (2005) Cancer Res., 65, pp. 2993-2995Pailard, F., Finot, F., Mouche, I., Prenez, A., Vericat, J.A., Use of primary cultures of rat hepatocytes to predict toxicity in the early development of new chemical entities (1999) Toxicol. In Vitro, 13, pp. 693-700Boya, P., Gonzalez-Polo, R.A., Poncet, D., Andreau, K., La Vieira, H., Roumier, T., Perfettini, J.L., Kroemer, G., Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine (2003) Oncogene, 22, pp. 3927-3936Bidère, N., Lorenzo, H.K., Carmona, S., Laforge, M., Harper, F., Dumont, C., Senik, A., Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis (2003) J. Biol. Chem., 278, pp. 31401-31411Guicciardi, M.E., Deussing, J., Miyoshi, H., Bronk, S.F., Svingen, P.A., Peters, C., Kaufmann, S.H., Gores, G.J., Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c (2000) J. Clin. Invest., 106, pp. 1127-1137Ishisaka, R., Utsumi, T., Kanno, T., Arita, K., Katunuma, N., Akiyama, J., Utsumi, K., Participation of a cathepsin L-type protease in the activation of caspase-3 (1999) Cell Struct. Funct., 24, pp. 465-470Werneburg, N.W., Guicciardi, M.E., Bronk, S.F., Gores, G.J., Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent (2002) Am. J. Physiol. Gastrointest. Liver Physiol., 283, pp. G947-G956Pedersen, P.L., Tumor mitochondria and the bioenergetics of cancer cells (1978) Prog. Exp. Tumor Res., 22, pp. 190-274Lu, F., Reactive oxygen species in cancer, too much or too little? (2007) Med. Hypotheses, 69, pp. 1293-1298Bize, I.B., Oberley, L.W., Morris, H.P., Superoxide dismutase and superoxide radical in Morris hepatomas (1980) Cancer Res., 40, pp. 3686-3693Cheeseman, K.H., Emery, S., Maddix, S.P., Slater, T.F., Burton, G.W., Ingold, K.U., Studies on lipid peroxidation in normal and tumour tissues. The Yoshida rat liver tumour (1988) Biochem. J., 250, pp. 247-25